Clinical Utility of a Low-Cost Hand-Held Breast Scanner
NCT ID: NCT02762565
Last Updated: 2021-08-16
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
89 participants
INTERVENTIONAL
2015-02-28
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Utility Study of a Low-Cost Hand-Held Breast Scanner
NCT02597452
Study of iBreast, a Handheld Device to Detect Breast Abnormalities During Screening Visits for Breast Cancer
NCT04761055
A Cost-Effective Handheld Breast Scanner for Use in Low Resource Environments: A Validation Study
NCT02814292
Tactile Breast Imaging Sensor for Tumor Malignancy Characterization
NCT02603211
Assessment of Automated Breast Ultrasound
NCT02386176
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
breast scanner
PEFS system (Product Name: Intelligent Breast Exam™ or iBE™
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PEFS system (Product Name: Intelligent Breast Exam™ or iBE™
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Women and men with symptomatic breast lump (either by palpation or imaging) OR
* Asymptomatic women presenting to the imaging center for a screening mammogram.
* Signed Informed Consent
Exclusion Criteria
* Patients who previously participated in this study and are returning to the Women's Imaging Center for follow-up diagnostic tests
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abramson Cancer Center at Penn Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ari Brooks, MD
Role: PRINCIPAL_INVESTIGATOR
Abramson Cancer Center at Penn Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UPCC 24114
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.